Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy
|
February 23, 2012
Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom
Christian G Giske, Inga Fröding, Chowdhury Mehedi Hasan, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 2007
Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals
Maria Virginia Villegas, Juan Nicolas Kattan, Adriana Correa, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 30, 2009
2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships
Robert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2024
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
Angela Glen, Roland W Bürli, David Livermore, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy
|
February 23, 2012
Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom
Christian G Giske, Inga Fröding, Chowdhury Mehedi Hasan, et al.
Antimicrobial Agents and Chemotherapy
|
April 4, 2007
Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals
Maria Virginia Villegas, Juan Nicolas Kattan, Adriana Correa, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 30, 2009
2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships
Robert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 31, 2024
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
Angela Glen, Roland W Bürli, David Livermore, et al.
Page
of 2